chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she was hurting at her chest/ Chest pain; on her left arm hurt real bad that's what the clot on her left arm; on her left arm hurt real bad that's what the clot on her left arm; She passed away; heart attack; This is a spontaneous report from a contactable consumer.  An 87-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at single dose for COVID-19 immunisation. Medical history included diabetes mellitus, for which she was taking a pill like an hour before she would take her meal. On Monday (Jan2021) the patient experienced was hurting at her chest/ chest pain, her left arm hurt real bad as she had a blockage in her left arm/clot on her left arm, and they wanted to put in a stent and after the surgery it went well and she all go home in two days. The patient was hospitalized in Jan2021 due to the events. She had a heart attack and that the chamber between the dividers had a hole in it and her heart tissue was too thin so much thin she couldn't repair it. The patient passed away on 26Jan2021. The patient was tested negative for COVID-19 on unknown date.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: She passed away
Extremely high resting rate - 130-140bpm while sleeping.  Fever of 102F, chills.  Fever disappeared at about 2pm on the 19th but came back at 8pm.
Information has been received from a physician concerning a 7 year old female who, on an undisclosed date, was vaccinated with 0.5 ml of Varivax. After being vaccinated the patient developed swollen eyes and her throat was swollen, and was subsequently rushed to the emergency room (ER). The reporting physician considered the events to be immediately life-threatening. No lot number was provided. At the time of reporting the patient's status was unknown. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Left deltoid region became erythematous, warm & induration following immunization.  Systemic fatigue.  Began to improve 48 hours later. Pt believes it was @ location of PNEUMOVAX.
Headache, arm swelling at site, hot to touch. Hard, muscle pain, fatigue, nauseousness, feeling unwell ,
pt reported by mom to have turned blue in car seat p/coming from hosp visit;911 called CPR done pt was taken to hosp;
I had a cardiac health event and I had to go to the hospital. I had a headache, blood pressure 189, and heart racing. They did test on me. They EKG, scan, and monitoring to me. They said it was some glitching but nothing serious. They prescribed me medication. I woke up with headache and vomiting a couples days later. I went back to the hospital, and they did a brain scan. They found an aneurism and because of the placement they decided not to remove it. I am doing treatment.
PT. HAD 2 VARICELLA VACCINES IN HER LIFE TIME AND WAS DIAGNOSED WITH VARICELLA 9/27/07
Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and then administered. The state CDC requested that a VAERS form be submitted for this patient.
Dizziness mid morning, to the point that patient felt that she might pass out. Hives, in trunk area of body by evening. The next day hives down extremities. Started taking Benedryl as hive onset. Monday morning, 28th, hives around neck. Breathing felt heavy. Continued Benadryl dosage and by Wed./Thurs. symptoms gone. Patient has a history of hives approx. 24hrs after taking or eating something that she shouldn't have.
9-16-21 at 11:06am via phone: Patient complains of discomfort in chest. She feels like she needs to burp but nothing comes up;  "like a bubble is my chest." Today, there she has pain (scale 5 out of 10) when she inhales. It began yesterday after the shot but she thought nothing of it. It has gotten worse since yesterday. She denies rash, hives and swelling of lips or tongue and did not sound at all out of breath on the phone. I recommended she immediately call her physician.
Patient came down with shingles anyway, diagnosed 5/19/09. Rash and blisters on face...lip and below lip and in eye.  Spent $300.00 on vaccine and didn't expect to get the disease 4 months later!
This case was reported by a pharmacist via sales rep and described the occurrence of injection site swelling in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX (subcutaneous). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site swelling, injection site erythema, injection site infection and inappropriate route of vaccination. The patient was treated with antibiotics nos. On an unknown date, the outcome of the injection site swelling, injection site erythema and injection site infection were not recovered/not resolved and the outcome of the inappropriate route of vaccination was unknown. The reporter considered the injection site swelling to be probably related to SHINGRIX. It was unknown if the reporter considered the injection site erythema and injection site infection to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX subcutaneously which led to inappropriate route of vaccination and had reported redness, swelling and infection at injection site. The healthcare professional (HCP) did not provide patient's date of birth and lot number or expiry date of SHINGRIX. The HCP was driving at the time of reporting and had limited information.
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (splitting headache), NAUSEA (nausea) and FATIGUE (extreme fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (splitting headache), NAUSEA (nausea) and FATIGUE (extreme fatigue). At the time of the report, HEADACHE (splitting headache), NAUSEA (nausea) and FATIGUE (extreme fatigue) had resolved. Not Provided          Concomitant medications were not reported.  No treatment information was provided.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In or around 10-MAY-2017, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Approximately one day after receiving ZOSTAVAX, the patient began to experience right sided ear pain for three days. The patient then suffered sudden and severe right sided facial droop with eye drainage and was hospitalized and diagnosed with Bell's Palsy. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient's symptoms have resulted in physical limitations not present prior to receiving the ZOSTAVAX. The patient also experienced mental and emotional distress due to resulting physical limitations and the seriousness of patient's condition. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered to be not recovered. Upon internal review, Bell's Palsy was determined to be medically significant. Bell's Palsy was considered to be disabling. Additional information has been requested.
Severe headache; Nausea; exposure during pregnancy; Throat sore; Cheeks flushed; Mouth numb; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (exposure during pregnancy), OROPHARYNGEAL PAIN (Throat sore), FLUSHING (Cheeks flushed), HYPOAESTHESIA ORAL (Mouth numb) and HEADACHE (Severe headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma, Shellfish allergy, Vegetable allergy (Egg plant) and Allergy to nuts (Hazelnut).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 03-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (exposure during pregnancy), OROPHARYNGEAL PAIN (Throat sore), FLUSHING (Cheeks flushed) and HYPOAESTHESIA ORAL (Mouth numb). On 04-Mar-2021, the patient experienced HEADACHE (Severe headache) and NAUSEA (Nausea). On 03-Mar-2021, EXPOSURE DURING PREGNANCY (exposure during pregnancy), OROPHARYNGEAL PAIN (Throat sore), FLUSHING (Cheeks flushed) and HYPOAESTHESIA ORAL (Mouth numb) had resolved. At the time of the report, HEADACHE (Severe headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient doctor recommended not to receive second dose and Patient wanted to know how to proceed if she only received one dose of vaccine . No concomitant medications were provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Mar-2021: Follow up received contains No new information .
Stools became more mucous-filled and had streaks of blood the day after vaccination.  Seen in my office where hemoccult was positive.  She was otherwise well-appearing, so was sent home.  The following day she had more blood in stool and was not feeding as well as usual.  Went to ER that night (3/11/15). KUB was negative, CBC and RP were unremarkable, CRP was normal.  Fed well in ER so was discharged home.  She was given a diagnosis of possible viral gastroenteritis vs. milk protein allergy at the time. After her 4-month vaccines (Dtap, Hib, IPV, PCV, Rotarix) were given, she again had bloody stools the following day.
6 days after second vaccine hives over body. Prednisone five day course given beginning February. Hives resolved for one week, returned one week later inclusive of abd pain. Hives and or abd pain continue almost daily. Rheum labs negative basic panel normal. Allergist appt scheduled
High fevers within 24 hours after vaccine. Seizures (fever associated) had been controlled until after this vaccine. Patient had continuous seizures for 7-10 days and drop seizures.
Redness, rash, no swelling around injection site. Fever 102F flu symptoms went to Physician Dx with viral illness/pharyngitis.
Chills, headache, sore arm, red welt on arm; chills and headache resolved with ibuprofen and Tylenol; sore arm and red welt began resolving after 5 days.
Fainted 10 minutes after administration.  High fever (102.4 measured t+2 hours after 1000MG of tylenol), aches, severe muscular cramps, chills, diarrhea, nausea lasting in varying severity for 40 hours after injection.
This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 21-DEC-2018, the patient was vaccinated with improperly stored dose of PEDVAXHIB lot # R014261, expiration date 25-MAR-2021 or lot # R005118, expiration date 28-NOV-2020 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (it was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient). Sender's Comments: US-009507513-1901USA000071.
Pt complained of chest pain within 5 minutes of vaccine at mass vac event. Pt monitored one on one by Dr. pain 8/10 to 5/10 to 2/10 after 10-12 minutes. no SOB, no deficit, no rash, no abd cramping.
pneumonia w/inc szs, 19MAY95 restless, poor appetite, 22MAY95 afeb elevated WBC, prolonged szs just prior to code (epileptic status) lasted >30mins
HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date; HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date), PRODUCT STORAGE ERROR (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date) and NO ADVERSE EVENT (No adverse event) in a 66-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 019H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date), PRODUCT STORAGE ERROR (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date), PRODUCT STORAGE ERROR (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date) and PRODUCT STORAGE ERROR (HCP administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date).    No concomitant drug information was provided by the reporter. Dosage text was reported as Additional Booster, Frequency-After, Done number 13. No adverse events post vaccination were reported. No treatment drug information was provided by the reporter.
Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm soreness) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness). At the time of the report, VACCINATION SITE PAIN (Arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment medications were not reported. The patient reported that the symptoms lasted 2 to 3 days.   This case was linked to MOD-2021-018176 (Patient Link).
Narrative: Generalized rash to torso and legs once after second dose of covid-19 vaccine. Reports rash full body 2nd episode post COVID- 19 infection (positive on 1/6/2022).
Flashes of dizziness, heaviness feeling in my arm, slight swelling, and seizure like movements in my arm.
This spontaneous report as received from Registered Nurse concerning  a patient of unknown age.    No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 11-JUL-2014,  the patient was vaccinated with a first dose of GARDASIL lot batch# reported as: V014219, expiration date: 05-OCT-2015 for prophylaxis (route of administration was not reported). On 16-AUG-2014, the patient recived the second dose of GARDASIL for prophylaxis, expiration date:19-JUN-2016 (dose, route of administration and  lot number were not reported). On 13-JUL-2015, the patient was vaccinated with a third dose of GARDASIL lot#: L018286, expiration date: 13-APR-2017 for prophylaxis (route of administration was not reported). And then the patient received a fourth dose of GARDASIL 9 lot #: N004799, expiration date: 15-NOV-2019 for prophylaxis (route of administration was not reported), on 01-AUG-2017, this was outside the recommendations. No adverse effects reported. Lot number V014219 is an invalid lot number for quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine.; Sender's Comments:  US-009507513-1709USA004392:
HA, body aches, low grade fever on 10/12/2015 and development of 2" wide band of giant hives, redness, itching and pain approx. 4" below injection site on right deltoid.  This band finally resolved approx. 10 days later with slight residual rash remaining.
Pt developed a knot, 2 X 1 inch wide with soreness. Has some fever in the area of the knot. Pain at site. Unable to lay on right side.
fever 103.6 F; arm soreness; drinking too much water; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 103.6 F), PAIN IN EXTREMITY (arm soreness) and THIRST (drinking too much water) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included GABAPENTIN and ATENOLOL for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PYREXIA (fever 103.6 F), PAIN IN EXTREMITY (arm soreness) and THIRST (drinking too much water). At the time of the report, PYREXIA (fever 103.6 F), PAIN IN EXTREMITY (arm soreness) and THIRST (drinking too much water) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details  were not included .
Immediately after the vaccine my arm was sore and I developed a slight red rash at the injection site. It went away within an hour. That afternoon, about 4 hours after the shot I was extremely fatigued. I went to bed fine but woke up at 1 in the morning feeling sick, and unable to sleep. Symptoms were nausea and restlessness. By morning, around 8am I had developed a fever that hovered around 101-102 degrees. I had the chills, nausea, and unbelievable body aches as if I had a hospitalized case of the flu (I?ve been hospitalized with the flu before). The symptoms were gone roughly 24-36 hours after the  shot.
This spontaneous report as received from an office manager refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 07-JUN-2014, the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular. Lot number reported as J014129, expiration date 05-OCT-2015. Other suspect therapies included VAQTA 0.5ml, intramuscular. Lot number J009441, expiration date 29-AUG-2015. On 07-JUN-2014, the patient received improperly stored GARDASIL, and VARIVAX (Merck) exposed to 31F for 86 hours. No adverse event were reported. This is one of several reports from the same source. Lot number J014129 is an invalid lot number for GARDASIL. It is a Lot number valid for VARIVAX (Merck). Additional information has been requested.
Dr scheduled an appt. at the vaccine clinic for a third booster vaccine of the Pfizer vaccine and it was administered  he had no adverse out come for reaction after monitoring.
This case was reported by a physician assistant to a sales representative and described the occurrence of injection site pain in an adult male subject (specific age unspecified) who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, absorbed (Boostrix) for prophylaxis. On an unspecified date on or before Oct 11 2005, the subject received 1st dose of Boostrix. The site of injection of Boostrix was not provided. At an unspecified time after vaccination with Boostrix, on an unspecified date on or before Oct 11 2005, the subject experienced injection site pain. At the time of initial reporting, Oct 11 2005, the outcome of the injection site pain was not reported. The physician assistant considered the injection site pain to probably be related to vaccination with Boostrix.
Following immunizations large swollen knot on thigh around injection site, red and hot, no fever reported. Came to doctor after, no treatment, symptoms resolved.
expired dose given to a patient; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) for prophylaxis.   In October 2022, the patient received Havrix. In October 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 1-Nov-2022 Reporter's comment: The nurse reported that an expired dose of Havrix was given to the patient a week ago (no exct date). The vaccine was expired in end of September (not exactly sure). The reporter did not had any further information and did not gave consent to follow-up. Additional supportive information: The patient received an expired dose of Havrix, which led to expired vaccine used. Expiry date was not coded as only month was reported day and year was unknown.
Roughly 4 to 5 days after receiving my booster. I started having hives break out from my arms hips an legs. Throughout my body just not face. After seeing a doctor I received a diagnoses of hives. The ran tests to find a reaction for any external or internal reactions. They had me stop taking my medication. The could not find the reason it started. They have prescribed a allergy pill. The hives only come back when I stop taking the medication. They prescribed Zyrtec. We tried a few and that was the best one that my body reacted to.  I have never had any reaction like this with any other vaccines including my first two Covid vaccines.   I seen a specialist Immunologist Dr- She really was not able to pinpoint anything. She couldn't say much about the vaccine because of no studies. She says he may go away. and that was months ago.